Aptevo
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptevo and other ETFs, options, and stocks.About APVO
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology.
APVO Key Statistics
APVO News
Aptevo Therapeutics announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to pu...
Loading... Loading... Aptevo Therapeutics Inc. APVO shares are trading lower Thursday after the company priced its $4.6 million public offering. The Details:...
Aptevo Therapeutics announced advancements in both clinical programs and one preclinical program. A heavily pretreated breast cancer patient, enrolled in the AL...
More APVO News
SEATTLE, WA / ACCESSWIRE / April 11, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-on...
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transition...